235 related articles for article (PubMed ID: 30698466)
1. Identification of a 26-lncRNAs Risk Model for Predicting Overall Survival of Cervical Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis.
Mao Y; Fu Z; Dong L; Zheng Y; Dong J; Li X
DNA Cell Biol; 2019 Apr; 38(4):322-332. PubMed ID: 30698466
[TBL] [Abstract][Full Text] [Related]
2. Identification of an immune-based mRNA-lncRNA signature for overall survival in cervical squamous cell carcinoma.
Mao Y; Chen R; Xia M; Guo P; Zeng F; Huang J; He M
Future Oncol; 2021 Jun; 17(18):2365-2380. PubMed ID: 33724869
[TBL] [Abstract][Full Text] [Related]
3. A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma.
Mao X; Qin X; Li L; Zhou J; Zhou M; Li X; Xu Y; Yuan L; Liu QN; Xing H
Gynecol Oncol; 2018 Apr; 149(1):181-187. PubMed ID: 29525275
[TBL] [Abstract][Full Text] [Related]
4. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
5. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871
[TBL] [Abstract][Full Text] [Related]
6. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
7. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
Zhang Z; Wang J; Han W; Zhao L
BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
[TBL] [Abstract][Full Text] [Related]
8. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
9. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
[TBL] [Abstract][Full Text] [Related]
10. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
[TBL] [Abstract][Full Text] [Related]
11. A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma.
Huang G; Huang Q; Xie Z; Zhou H; Cao J; Shi L; Yang M
Cancer Biomark; 2019; 26(3):239-247. PubMed ID: 31524143
[TBL] [Abstract][Full Text] [Related]
12. A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
Cao W; Liu JN; Liu Z; Wang X; Han ZG; Ji T; Chen WT; Zou X
Oral Oncol; 2017 Feb; 65():94-101. PubMed ID: 28109476
[TBL] [Abstract][Full Text] [Related]
13. Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer.
Shang C; Zhu W; Liu T; Wang W; Huang G; Huang J; Zhao P; Zhao Y; Yao S
Oncol Rep; 2016 Jun; 35(6):3185-97. PubMed ID: 27035672
[TBL] [Abstract][Full Text] [Related]
14. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
15. Constructing a Novel Signature Based on Immune-Related lncRNA to Improve Prognosis Prediction of Cervical Squamous Cell Carcinoma Patients.
Lv X; Liu L; Li P; Yuan Y; Peng M; Jin H; Qin D
Reprod Sci; 2022 Mar; 29(3):800-815. PubMed ID: 35075611
[TBL] [Abstract][Full Text] [Related]
16. A prognostic 4-lncRNA expression signature for lung squamous cell carcinoma.
Luo D; Deng B; Weng M; Luo Z; Nie X
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1207-1214. PubMed ID: 28835135
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
Wang R; Li Y; Du P; Zhang X; Li X; Cheng G
Life Sci; 2019 Sep; 233():116708. PubMed ID: 31369759
[TBL] [Abstract][Full Text] [Related]
18. A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).
Wang P; Jin M; Sun CH; Yang L; Li YS; Wang X; Sun YN; Tian LL; Liu M
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355656
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
Chen X; Liu L; Zhu W
Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of long non‑coding RNA competing interactions revealed potential biomarkers in cervical cancer: Based on a public database.
Wu WJ; Shen Y; Sui J; Li CY; Yang S; Xu SY; Zhang M; Yin LH; Pu YP; Liang GY
Mol Med Rep; 2018 Jun; 17(6):7845-7858. PubMed ID: 29620291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
